Bone Density Clinical Trials

8 recruitingLast updated: May 21, 2026

There are 8 actively recruiting bone density clinical trials across 5 countries. Studies span Not Applicable, Phase 2, Early Phase 1. Top locations include Charlottesville, Virginia, United States, Granada, Granada, Spain, Iowa City, Iowa, United States. Updated daily from ClinicalTrials.gov.


Bone Density Trials at a Glance

8 actively recruiting trials for bone density are listed on ClinicalTrialsFinder across 6 cities in 5 countries. The largest study group is Not Applicable with 2 trials, with the heaviest enrollment activity in Charlottesville, Granada, and Iowa City. Lead sponsors running bone density studies include University of Virginia, Rutgers, The State University of New Jersey, and Centre Hospitalier Universitaire de Nīmes.

Browse bone density trials by phase

About Bone Density Clinical Trials

Looking for clinical trials for Bone Density? There are currently 7 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Bone Density trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Bone Density clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting
Not Applicable

Metabolic Health, Bones and Nuts During Weight Loss in Adults

Obesity and OverweightWeight LossBone Density
Rutgers, The State University of New Jersey44 enrolled1 locationNCT06949280
Recruiting
Phase 2

Role of Estrogen on Skeletal Outcomes in FHA

Bone DensityBone StrengthFHA (Functional Hypothalamic Amenorrhea)
University of Virginia150 enrolled2 locationsNCT07010146
Recruiting
Phase 2

Bone Metabolism in 12-21 Year Olds Undergoing Glucagon Like Peptide (GLP)-1 Receptor Agonist Therapy

Obesity in childrenObesityLifestyle Modification+3 more
University of Virginia120 enrolled1 locationNCT06903923
Recruiting

CT-Based Changes in Bone and Marrow Among Patients on Oral Steroids

AsthmaBone Density, LowOral Steroid-Dependent Asthma (Disorder)
University of Iowa12 enrolled1 locationNCT04518722
Recruiting
Early Phase 1

Topic Simvastatin for Bone Regeneration

Dimensional ChangesBone Density
Universidad de Granada90 enrolled1 locationNCT07031778
Recruiting

Investigating the Relationship Between Temporal Bone CT, Bone Density, and Hearing Loss in Otosclerosis Patients

Vitamin D DeficiencyBone DensityOtosclerosis of Middle Ear
İbrahim Emir Yeşil86 enrolled1 locationNCT06830187
Recruiting
Not Applicable

Mediating Role of Myokines in the Dialogue Between Muscle and Bone Tissue in a Population of Healthy Women Aged 20-89 Years

Bone Density
Centre Hospitalier Universitaire de Nīmes280 enrolled2 locationsNCT06683222
Recruiting

The Impact of Hormonal Contraceptive Use and Lifestyle Factors on Fracture Risk and Bone Quality in Young Female Adults

Body CompositionPhysical ActivityOsteoporosis+8 more
Bundeswehr University Munich150 enrolled1 locationNCT06608862